Home/Filings/4/0001628280-19-009173
4//SEC Filing

KANE JOHN A 4

Accession 0001628280-19-009173

CIK 0001636422other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 9:01 PM ET

Size

10.7 KB

Accession

0001628280-19-009173

Insider Transaction Report

Form 4
Period: 2019-07-29
KANE JOHN A
Director
Transactions
  • Conversion

    Common Stock

    2019-07-29+23,58680,877 total
  • Conversion

    Series F Preferred Stock

    2019-07-295890 total
    Common Stock (589 underlying)
  • Conversion

    Common Stock

    2019-07-29+58981,466 total
  • Conversion

    Series E Preferred Stock

    2019-07-2923,5860 total
    Common Stock (23,586 underlying)
Footnotes (2)
  • [F1]Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
  • [F2]Each share of Series F Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.

Issuer

Health Catalyst, Inc.

CIK 0001636422

Entity typeother
IncorporatedVT

Related Parties

1
  • filerCIK 0001049356

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:01 PM ET
Size
10.7 KB